Biblio
Assessment of Motor Unit Potentials Duration as the Biomarker of DT-DEC01 Cell Therapy Efficacy in Duchenne Muscular Dystrophy Patients up to 12 Months After Systemic-Intraosseous Administration. Arch Immunol Ther Exp (Warsz). 2023;71(1):24.
. . Late effects of childhood cancer treatment in long-term survivors diagnosed before the age of 3 years - A multicenter, nationwide study. Cancer Epidemiol. 2022;80:102209.
Long-term brain status and cognitive impairment in children treated for high-risk acute lymphoblastic leukemia with and without allogeneic hematopoietic stem cell transplantation: A single-center study. Pediatr Blood Cancer. 2020:e28224.
. Mixed phenotype acute leukemia (MPAL): biological profile, clinical characteristic and treatment outcomes: report of the population-based study. Eur J Haematol. 2020.
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study. Bone Marrow Transplant. 2020.
. Infection profile in children and adolescents with bone marrow failures treated with allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2019:e13592.
. Regional HLA Differences in Poland and Their Effect on Stem Cell Donor Registry Planning. PLoS One. 2013;8(9):e73835.
.